Related references
Note: Only part of the references are listed.Changes in chest X-ray findings in 1-and 2-month group after treatment initiation for suspected pulmonary tuberculosis
Jang Ho Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
Factors associated with diagnostic delay in recurrent TB
Zhongyao Xie et al.
BMC PUBLIC HEALTH (2020)
Recurrent tuberculosis in patients infected with the predominant Mycobacterium tuberculosis outbreak strain in Denmark. New insights gained through whole genome sequencing
Dorte Bek Folkvardsen et al.
INFECTION GENETICS AND EVOLUTION (2020)
Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study
Xu-Bin Zheng et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study
Patrick George Tobias Cudahy et al.
BMC INFECTIOUS DISEASES (2020)
Surveillance of tuberculosis (TB) cases attributable to relapse or reinfection in London, 2002-2015
Baharak Afshar et al.
PLOS ONE (2019)
Recurrence Is a Noticeable Cause of Rifampicin-Resistant Mycobacterium tuberculosis in the Elderly Population in Jiangxi, China
Qiang Chen et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing
Nino Maghradze et al.
PLOS ONE (2019)
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis
S. E. Murthy et al.
BMC MEDICINE (2018)
Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study
Banurekha Velayutham et al.
PLOS ONE (2018)
Relapse Versus Reinfection of Recurrent Tuberculosis Patients in a National Tuberculosis Specialized Hospital in Beijing, China
Zhaojing Zong et al.
FRONTIERS IN MICROBIOLOGY (2018)
Estimated rates of recurrence, cure and treatment abandonment in patients with pulmonary tuberculosis treated with a four drug fixed dose combination regimen at a tertiary health care facility in the city of Rio de Janeiro
Vangie Dias da Silva et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2017)
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis
Medea Gegia et al.
LANCET INFECTIOUS DISEASES (2017)
Transmission is a Noticeable Cause of Resistance Among Treated Tuberculosis Patients in Shanghai, China
Chijioke A. Nsofor et al.
SCIENTIFIC REPORTS (2017)
Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan
Jamshid Gadoev et al.
PLOS ONE (2017)
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models
Rein M. G. J. Houben et al.
LANCET GLOBAL HEALTH (2016)
The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study
Mahmood Moosazadeh et al.
LUNG INDIA (2015)
Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States
Julia D. Interrante et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)
The Temporal Dynamics of Relapse and Reinfection Tuberculosis After Successful Treatment: A Retrospective Cohort Study
Florian M. Marx et al.
CLINICAL INFECTIOUS DISEASES (2014)
Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda
H. Luzze et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?
Juan-Pablo Millet et al.
PLOS ONE (2013)
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
Josephine M. Bryant et al.
LANCET RESPIRATORY MEDICINE (2013)
Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda
A. Nakanwagi-Mukwaya et al.
PUBLIC HEALTH ACTION (2013)
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009
M. Gegia et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting
A. C. Pettit et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis
Mara Cardoso Oelemann et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis
Philip Supply et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Tuberculosis recurrence and mortality after successful treatment:: Impact of drug resistance
Helen Cox et al.
PLOS MEDICINE (2006)
Recurrence in tuberculosis: relapse or reinfection?
ML Lambert et al.
LANCET INFECTIOUS DISEASES (2003)
Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis
A Krüüner et al.
CLINICAL INFECTIOUS DISEASES (2002)
Evaluation of a rapid PCR-based epidemiological typing method for routine studies of Mycobacterium tuberculosis
MD Yates et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Share Paper
